TGTPG GP A, LLC

Institutional investor · Portfolio as of Q2 2025

Top Holdings9 positions

Checking export access…
Activity:

LIFESTANCE HEALTH GROUP INC

160.7M$830.9M44.3%———
Unchanged
0

LIFE TIME GROUP HOLDINGS INC

21.4M$649.2M34.6%———
Decreased
0

SIONNA THERAPEUTICS INC

6.7M$117M6.2%———
Increased
62

Amneal Pharmaceuticals Inc

12.3M$99.7M5.3%———
Unchanged
0

CERIBELL INC

4M$74.3M4.0%———
Unchanged
0
TRTXTRTX
REIT

TPG RE Finance Trust Inc

7.1M$54.7M2.9%———
Unchanged
0

BICARA THERAPEUTICS INC

3M$28M1.5%———
Unchanged
0

Allogene Therapeutics Inc

18.7M$21.1M1.1%———
Unchanged
0

Rallybio Corp

3M$1M0.1%———
Unchanged
0
$1.9B
AUM
9
Positions
Q2 2025
Filing
—
HI score
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q2'25
New0%Increased2%Decreased8%Exited90%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.5 years
<1Q0%1-4Q33%1-2Y0%2Y+67%

TPG GP A, LLC manages $1.9B across 9 positions as of Q2 2025. Top holdings: LFST (44.3%), LTH (34.6%), SION (6.2%). Fund DNA: Momentum Trader.

Top holdings by portfolio weight

Total AUM$2B
LFST44.29%
LTH34.61%
SION6.24%
AMRX5.32%
CBLL3.96%
TRTX2.92%
BCAX1.49%
ALLO1.13%
RLYB0.05%
ENTG0.00%

Portfolio allocation by GICS sector

Sectors3
Healthcare62.48%
Consumer Cyclical34.61%
Real Estate2.92%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Consumer Cyclical
Compare DNA across all funds

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used